https://www.selleckchem.com/products/ttk21.html
PCO analysis explained 34.6% of the total variability of the data (PERMANOVA; p .0001). Subsequently, SIMPER analysis showed that miR-146, miR-155, and miR-126 together, with some clinical parameters, contributed to 50% of the between-group significance. Finally, the CAP analysis developed showed a correct classification of 89.01% with the analysed parameters. A platform using a combination of clinical variables and exomiRs could be used to classify individuals with T2D as risk for developing DKD. A platform using a combination of cli
إعجاب
علق
شارك
